Incyte Announces More Than 20 Abstracts Accepted for Presentation at the European Hematology Association 2026 Congress
Data from pivotal Phase 3 frontMIND trial evaluating tafasitamab (Monjuvi ® /Minjuvi ® ) in first-line diffuse large b-cell lymphoma (DLBCL) selected for prestigious Plenary Abstracts Session Oral and poster presentations to feature new data for …